Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1225.36	-1057.17	-79.76
Graham Fair Price	3.92	1.61	1.55
PEG	-31.12	0.13	-0.19
Price/Book	66.52	0.40	0.24
Price/Cash Flow	-34.03	1.34	2.03
Prices/Earnings	-2.55	4.62	4.74
Price/Sales	16.24	4.76	-4.10
Price/FCF	-34.03	1.34	2.03
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	16.16	1.16	1.00
Operating Margin	-70.28	0.37	-1.23
ROA	77.40	< 0.005	< 0.005
ROE	0.01	0.02	70.88
ROIC	0.01	< 0.005	-28.82
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.53	1.00	-47.69
Dividends QOQ	0.15	-0.83	462.94
EBIT QOQ	8.14	-0.57	-92.94
EPS QOQ	-0.25	0.36	41.47
FCF QOQ	-0.53	1.52	185.17
Revenue QOQ	-1.36	2.43	79.13
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	-165.40	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.82	0.68	-16.69
Quick Ratio	20.21	61.05	202.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.90	2.30	-20.50
Cash	1.34	1.19	-10.99
Capex	-0.01	< 0.005	98.61
Free Cash Flow	0.34	0.69	100.66
Revenue	-0.17	0.19	13.89
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	16.38	61.05	272.62
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-75.34	-848.17	-1025.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating